Abstract:Although the role of orthotopic liver transplantation (OLT) in the treatment of hepatocellular carcinoma (HCC) has improved over the years, tumor recurrence is still a major imitation of long-term survival even after radical transplantation treatment.1Okuda K. Ohtsuki T. Obata H. et al.Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients.Cancer. 1985; 56: 918-928Crossref PubMed Scopus (1717) Google Scholar Thoracic metastasis is the most common site of extrahepatic spreads. The role of surgery for thoracic metastasis is not known, and until now there have been few reports about surgical resection for thoracic HCC metastasis after liver transplantation. We evaluate the surgical efficacy in the treatment of thoracic HCC recurrence after OLT. Between October of 2003 and September of 2007, 5 patients who had undergone OLT for HCC demonstrated resectable thoracic HCC recurrence and were admitted to the Department of Thoracic and Cardiovascular Surgery without other identifiable recurrence foci. Thoracic recurrence was located in the right lower lobe and the upper lobe in 1 patient, the right lower lobe in 1 patient, the fourth to sixth right costal cartilage and the right lower lobe in 1 patient, the middle lobe in 1 patient, and the right upper lobe in 1 patient. They underwent standard lobectomy or wedge resection for thoracic recurrence. The specimen pathology showed all low differentiated metastatic HCC, except a benign nodule of the right lower lobe in the patient with recurrence in the costal cartilage. After surgical resection, no patient received chemotherapy or other adjuvant treatments. Patients were followed up at interval with laboratory analysis and whole body scan for physical conditions and a second recurrence. HCC recurrence developed in the left adrenal gland in 1 patient 6 months after right lower lobectomy. Left adrenal gland resection was performed under laparoscopic surgery, and the pathology revealed low differentiated metastatic HCC. The other 4 patients have no recurrence, and all 5 patients are currently alive. The time from transplant to diagnosis of thoracic recurrence ranged from 8 to 33 months, with an average period of 18.6 months. The survival time from transplant ranged from 16 to 85 months, with a mean time of 37.4 months. The survival time from thoracic resection ranged from 3 to 53 months, with an average time of 17.8 months. The study was retrospective and approved by all 5 patients. All thoracic surgical management, survival time, and other clinical parameters are reviewed in Table 1.Table 1Characteristics of patients and data of recurrence, metastasectomy, survival timePatient12345GenderMaleMaleMaleMaleMaleAge, y4966476337Thoracic recurrence LocationRUL, RLLRLLRCC, RLLRMLRUL Size (cm)1, 23.55, 0.531 ResectionWedgeLobectomyRib resection, LobectomyWedgeWedge Tumor differentiation gradeLow, lowLowLow, benignLowLow Postresection treatmentNoNoNoNoNoSecondary recurrenceNoYesNoNoNo Location—Left adrenal gland——— Size (cm)—3——— Resection—Laparoscope——— Tumor differentiation grade—Low——— Postresection treatment—No———AliveYesYesYesYesYesTime from transplant (mo) to thoracic recurrence323312811 to secondary recurrence—39———Survival time from TRR (mo)5316893RUL, Right upper lobe; RLL, right lower lobe; RCC, right costal cartilage; RML, right middle lobe; TRR, thoracic recurrence resection. Open table in a new tab RUL, Right upper lobe; RLL, right lower lobe; RCC, right costal cartilage; RML, right middle lobe; TRR, thoracic recurrence resection. Liver transplantation was considered as radical surgery macroscopically (the tumor is resected completely and there is no residual tumor tissue from surgeon's eye and radiography) for patients with HCC. However, tumor recurrence was the major limitation of long-term survival after liver transplantation. Although intrahepatic recurrence predominated, the most common location of extrahepatic metastasis was the thorax.2Si M.S. Amersi F. Golish S.R. Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival.Am Surg. 2003; 69: 879-885PubMed Google Scholar Survival for patients with recurrence was significantly shorter than for patients undergoing transplantation for HCC without recurrence. Thoracic recurrence was mainly detected by biochemical and radiographic evidence. Increased alpha-fetoprotein level was generally an early key indicator for any advanced radiographic evidence of HCC recurrence. Enhanced computed tomography, ultrasonography, positron emission tomography, and radionuclide bone imaging were also important as routine initial or advanced screening for recurrence evidence. Although some studies have shown that only adjuvant treatments for posttransplant HCC recurrence without surgical resection may be good to increase survival, a better benefit may be obtained from metastasectomy.3Bates M.J. Farkas E. Taylor D. McFadden P.M. Pulmonary resection of metastatic hepatocellular carcinoma after liver transplantation.Ann Thorac Surg. 2008; 85: 412-415Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar The type of surgical resection was based on the patients' anatomic and physiologic considerations. Radical lobectomy was preferred, and wedge resection was considered according to the recurrence anatomic site, numbers, pulmonary function, and even the request of the patients. All 5 patients are currently alive, and the average survival time from thoracic resection is 17.8 months, which is similar to the results of previous reports.3Bates M.J. Farkas E. Taylor D. McFadden P.M. Pulmonary resection of metastatic hepatocellular carcinoma after liver transplantation.Ann Thorac Surg. 2008; 85: 412-415Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar Although the size of our study population was small, the survival time in these patients is encouraging. A larger study may be necessary to assess the possible benefits of surgical resection and surgical types for resectable thoracic metastasis after liver transplantation for HCC. These aims should be accomplished with advanced investigation in a larger population and a longer follow-up for similar patients. There have been few reports about surgical resection for thoracic metastasis after liver transplantation for HCC. In our series, metastasectomy for resectable thoracic HCC recurrence after liver transplantation was encouraging and is suggested as a reasonable treatment.

Efficacy of pulmonary resection for primary hepatocellular carcinoma patients with pulmonary metastasis]

Surgical Resection of Resectable Thoracic Metastatic Hepatocellular Carcinoma after Liver Transplantation

Efficacy of Surgical Resection for Pulmonary Metastases from Hepatocellular Carcinoma.

Role of Re-Resection in Treatment of Recurrent Hepatocellular Carcinoma

Metachronous Pulmonary and Adrenal Metastases after Liver Transplantation for Hepatocarcinoma

Clinical Factors Predictive of a Better Prognosis of Pulmonary Metastasectomy for Hepatocellular Carcinoma.

Therapeutic Significance and Indications of Pulmonary Metastasectomy for Hepatocellular Carcinoma Following Liver Resection

Long-Term Survival of Patients with Hepatocellular Carcinoma with Pulmonary and Adrenal Metastasis: A Case Report

Palliative Radiation Therapy for Pulmonary Metastases from Hepatocellular Carcinoma

Outcome and Survival Analysis of Multicenter Lung Metastasectomy for Primary Liver Tumor with Pulmonary Metastasis

Percutaneous CT-guided Radiofrequency Ablation for Unresectable Hepatocellular Carcinoma Pulmonary Metastases

Hepatectomy for primary liver cancer in 1102 cases

Surgical treatment of hepatic metastases of lung cancer

Long-term outcomes after hepatic resection combined with radiofrequency ablation for initially unresectable multiple and bilobar liver malignancies.

Surgical Treatment of Recurrent Hepatocellular Carcinoma.

Therapeutic Effects of Hepatic Resection in Liver Metastasis of Colorectal Cancer

Efficacy of salvage liver transplantation for patients with hepatoceliular carcinoma after liver resection

Prognostic Analysis of Pulmonary Metastases from Hepatocellular Carcinoma.

Efficacy of Laparoscopic Hepatectomy for the Treatment of Hepatocellular Carcinoma

Three Decades' Experience In Surgery Of Hepatocellular Carcinoma

Surgical Treatment of Primary Hepatoeellular Carcinoma: a 20-Year Clinical Experience in 7566 Patients